Thierry Nguyen

1.1k total citations
40 papers, 613 citations indexed

About

Thierry Nguyen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Thierry Nguyen has authored 40 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 20 papers in Pulmonary and Respiratory Medicine and 10 papers in Surgery. Recurrent topics in Thierry Nguyen's work include Colorectal Cancer Treatments and Studies (9 papers), Cancer Treatment and Pharmacology (9 papers) and Gastric Cancer Management and Outcomes (6 papers). Thierry Nguyen is often cited by papers focused on Colorectal Cancer Treatments and Studies (9 papers), Cancer Treatment and Pharmacology (9 papers) and Gastric Cancer Management and Outcomes (6 papers). Thierry Nguyen collaborates with scholars based in France, Albania and Argentina. Thierry Nguyen's co-authors include Xavier Pivot, Stéfano Kim, Antoine Thiery-Vuillemin, Christophe Borg, Martin Demarchi, Cristian Villanueva, L. Chaigneau, Bruno Heyd, Marine Jary and Fernando Bazán and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Hepatology and International Journal of Cancer.

In The Last Decade

Thierry Nguyen

39 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thierry Nguyen France 15 281 203 159 95 93 40 613
Hiroki Ikezawa Japan 11 300 1.1× 116 0.6× 115 0.7× 60 0.6× 77 0.8× 32 512
David Saavedra-Pérez Spain 9 276 1.0× 163 0.8× 149 0.9× 142 1.5× 94 1.0× 29 580
C Mossetti Italy 13 380 1.4× 350 1.7× 115 0.7× 77 0.8× 131 1.4× 31 745
Domenico Guarneri Italy 14 223 0.8× 276 1.4× 141 0.9× 97 1.0× 62 0.7× 52 607
Francis Parnis Australia 14 328 1.2× 457 2.3× 112 0.7× 160 1.7× 186 2.0× 60 761
L. Cals France 15 495 1.8× 253 1.2× 109 0.7× 102 1.1× 79 0.8× 41 674
Marilyn Mulay United States 11 365 1.3× 250 1.2× 71 0.4× 104 1.1× 243 2.6× 17 644
A Iveson United Kingdom 6 298 1.1× 128 0.6× 101 0.6× 64 0.7× 60 0.6× 8 530
Hae Su Kim South Korea 12 270 1.0× 173 0.9× 78 0.5× 92 1.0× 147 1.6× 26 511
Raphael Brandão Moreira United States 11 504 1.8× 369 1.8× 83 0.5× 99 1.0× 106 1.1× 30 719

Countries citing papers authored by Thierry Nguyen

Since Specialization
Citations

This map shows the geographic impact of Thierry Nguyen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Nguyen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Nguyen more than expected).

Fields of papers citing papers by Thierry Nguyen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Nguyen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Nguyen. The network helps show where Thierry Nguyen may publish in the future.

Co-authorship network of co-authors of Thierry Nguyen

This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Nguyen. A scholar is included among the top collaborators of Thierry Nguyen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Nguyen. Thierry Nguyen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spehner, Laurie, Adeline Bouard, Marie Kroemer, et al.. (2025). Clinical and biological determinants of multimodal metronomic chemotherapy efficacy in chemo‐refractory gastrointestinal cancers. International Journal of Cancer. 158(1). 182–192.
2.
Calcagno, Fabien, Hamadi Almotlak, Guillaume Mouillet, et al.. (2022). Evaluation of drug-drug interactions among patients with metastatic prostate cancer in routine care.. Journal of Clinical Oncology. 40(6_suppl). 111–111. 1 indexed citations
3.
Royer, Bernard, Antonin Schmitt, Thierry Nguyen, et al.. (2020). Exposure‐response analysis of Raltitrexed assessing liver toxicity. British Journal of Clinical Pharmacology. 87(3). 1327–1337. 4 indexed citations
4.
Laheurte, Caroline, Fabien Calcagno, Laura Boullerot, et al.. (2019). Metronomic cyclophosphamide induces regulatory T cells depletion and PSA‐specific T cells reactivation in patients with biochemical recurrent prostate cancer. International Journal of Cancer. 147(4). 1199–1205. 14 indexed citations
5.
Berdelou, A., Isabelle Borget, Yann Godbert, et al.. (2017). Lenvatinib for the Treatment of Radioiodine-Refractory Thyroid Cancer in Real-Life Practice. Thyroid. 28(1). 72–78. 102 indexed citations
6.
Kim, Stéfano, Damien Montange, Thierry Nguyen, et al.. (2017). A simple and fast LC–MS/MS method with a very high sensitivity for the measurement of raltitrexed in human plasma. Journal of Chromatography B. 1060. 240–246. 3 indexed citations
7.
Joly, Florence, Jean‐Christophe Eymard, Laurence Albigès, et al.. (2017). A prospective observational study on the evaluation of everolimus-related adverse events in metastatic renal cell carcinoma after first-line anti-vascular endothelial growth factor therapy: the AFINITE study in France. Supportive Care in Cancer. 25(7). 2055–2062. 4 indexed citations
8.
9.
Dobi, Erion, Astrid Pozet, Hamadi Almotlak, et al.. (2015). Carboplatin-etoposide combination chemotherapy in metastatic castration-resistant prostate cancer: A retrospective study. Molecular and Clinical Oncology. 3(6). 1208–1212. 13 indexed citations
10.
Jary, Marine, François Ghiringhelli, Marion Jacquin, et al.. (2014). Phase II multicentre study of efficacy and feasibility of dose-intensified preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) in resectable gastroesophageal cancer. Cancer Chemotherapy and Pharmacology. 74(1). 141–150. 6 indexed citations
11.
Fiteni, Frédéric, Marine Jary, Franck Monnien, et al.. (2014). Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy. BMC Gastroenterology. 14(1). 143–143. 19 indexed citations
12.
13.
14.
Isambert, Nicolás, Jean Pierre Delord, Jean Marc Tourani, et al.. (2013). How to manage intravenous vinflunine in cancer patients with renal impairment: results of a pharmacokinetic and tolerability phase I study. British Journal of Clinical Pharmacology. 77(3). 498–508. 8 indexed citations
15.
Curtit, Elsa, Laura Mansi, É. Viel, et al.. (2012). KIT et KIT : de la biologie à la clinique. Bulletin du Cancer. 99(2). 191–197. 1 indexed citations
16.
17.
Villanueva, Cristian, Fernando Bazán, Stéfano Kim, et al.. (2011). Cabazitaxel. Drugs. 71(10). 1251–1258. 41 indexed citations
18.
Thiery-Vuillemin, Antoine, Erion Dobi, Thierry Nguyen, et al.. (2010). Duration: escalation study of oral etoposide with carboplatin in patients with varied solid tumors. Anti-Cancer Drugs. 21(10). 958–962. 3 indexed citations
19.
Thiery-Vuillemin, Antoine, L. Chaigneau, N. Méaux-Ruault, et al.. (2008). Anticancer therapy in patients with porphyrias: evidence today. Expert Opinion on Drug Safety. 7(2). 159–165. 2 indexed citations
20.
Pivot, Xavier, L. Chaigneau, Thierry Nguyen, et al.. (2008). Ixabepilone, a novel epothilone analog in the treatment of breast cancer. Expert Opinion on Investigational Drugs. 17(4). 593–599. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroki Ikezawa Breakdown of academic impact, for papers by David Saavedra-Pérez Breakdown of academic impact, for papers by C Mossetti Breakdown of academic impact, for papers by Domenico Guarneri Breakdown of academic impact, for papers by Francis Parnis Breakdown of academic impact, for papers by L. Cals Breakdown of academic impact, for papers by Marilyn Mulay Breakdown of academic impact, for papers by A Iveson Breakdown of academic impact, for papers by Hae Su Kim Breakdown of academic impact, for papers by Raphael Brandão Moreira
Rankless by CCL
2026